Ann: SOLVE-CRT trial data accepted into HRS conference, page-6

I note that Stock_head has put out an article on various ASX listed companies going through FDA trial process at the moment, one of which mentioned was EBR - Morgan's health analyst
Scott Power, commented -

"EBR has been working on a new kind of leadless pacemaker system called WiSE.

"The company is due to release top-line results in May from its pivotal SOLVE-CRT trial into WiSE.Power said the results will be a major catalyst for the ASX company and it can then put in a submission to the US FDA, which it is expected to do by the end of CY23 with hopefully approval by mid-2024.

“We have a high degree of confidence that the results will be positive and if it is you will see the share price lift significantly higher,” Power said.

https://stock*head.com.au/company/ebr-systems-ebr/

(remove the * from that link for it to open)